Strategic Supply Chain Leadership: Driving Biopharma Growth

By Alyssa Colón, Senior Manager of Quality, Cell and Gene Therapy, and Shefali Mitra, Manager of cGMP Chemical Supply Chain Management for Bioprocessing

Strategic and risk-averse sourcing is pertinent to safeguarding processes and ensuring continuous raw material supply. A number of factors increase this urgency, including geopolitical tensions and long lead times for critical materials, but even the smallest supply chain vulnerabilities can place a process at risk. Because every manufacturing process has its own unique requirements and challenges, sponsors must establish a reliable procurement strategy from the earliest stages of development.

There are several essential considerations for procurement, starting with how to establish selection criteria and determine whether a process requires RUO or GMP-compliant materials. From there, sponsors must evaluate if suppliers offer the price, quality, and service needed to ensure value, which entails vetting the effectiveness of their procedures from contamination control to change management. Download the full article to learn more about how to build a reliable raw material sourcing strategy from the ground up.